co.grimaldi
Submits third-party assay reports on material purchased directly. Based in Porto.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
11
n=11
Annotations
0
n=0
Median purity submitted
98.99%
n=11
Suppliers covered
7
n=11
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041845 | TB-500 | JEEP | JEEP-2602-V3434 | Janoshik | 2026-Q3 | 99.72 | 4.04 | 102.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042061 | Sermorelin | TFC | TFC-2605-Y6440 | Medutest | 2026-Q3 | 99.57 | 4.06 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042866 | BPC-157 | GGPeps | GGPE-2512-G2285 | Janoshik | 2026-Q2 | 98.11 | 3.95 | 105.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042527 | PEG-MGF | ERP | ERP-2509-K6500 | Kestrel | 2026-Q1 | 97.92 | 4.96 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042948 | Ipamorelin | KP | KP-2512-X4190 | Nordanalyt | 2026-Q1 | 98.55 | 2.68 | — | Laboratory-retained | 2 | FAIL |
| AX-2025-020916 | Pemvidutide | CPC | CPC-2507-H2201 | Medutest | 2025-Q4 | 98.66 | 3.85 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020444 | KPV | KP | KP-2509-N5148 | Janoshik | 2025-Q4 | 98.99 | 2.35 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020022 | MOTS-c | ERP | ERP-2508-M7270 | Kestrel | 2025-Q3 | 98.57 | 1.46 | 101.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019696 | Semaglutide | HJ | HJ-2507-E3085 | Janoshik | 2025-Q3 | 99.74 | 5.06 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020052 | Oxytocin | ERP | ERP-2503-A7432 | Janoshik | 2025-Q2 | 99.41 | 5.45 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004888 | TB-500 | ERP | ERP-2401-K6373 | Janoshik | 2024-Q2 | 99.62 | 3.27 | 90.2 | Supplier-supplied | 2 | MARGINAL |